Hepatocellular carcinoma: Updates in primary prevention

7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hepatocellular carcinoma is a significant cause of mortality worldwide and a growing problem in the United States. Treatment options are often limited, and median survival is less than 1 year, Thus, prevention may provide the best opportunity to alter the natural history of this disease. Primary prevention is best exemplified by the successes of such public health measures as universal hepatitis B vaccination. Such antiviral therapies as interferon may also have a role. Lessons can be learned from complementary and alternative medicine, Nevertheless, more work is needed in understanding hepatocarcinogenesis and in developing models to assess potential chemopreventive agents. Copyright © 2004 by Current Science Inc.

Cite

CITATION STYLE

APA

Fecht, W. J., & Befeler, A. S. (2004). Hepatocellular carcinoma: Updates in primary prevention. Current Gastroenterology Reports. Current Science Ltd. https://doi.org/10.1007/s11894-004-0024-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free